LCS
CALC icon

Levin Capital Strategies’s CalciMedica CALC Stock Holding History

Levin Capital Strategies’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,071
Closed -$16K – 250
2022
Q2 		$16K Buy
+1,071
New +$14.6K ﹤0.01% 259

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Levin Capital Strategies's CALC Position: Q3 2022 in Review

Levin Capital Strategies sold out of CalciMedica (CALC) in Q3 2022, closing a stake of 1,071 shares — an estimated $16K sold.

Levin Capital Strategies first reported a position in CALC in Q2 2022 and held it in 1 quarter. The position peaked at $16K in Q2 2022. 25 funds tracked by Wall St. Rank hold CALC as of Q3 2022.

  • Levin Capital Strategies reported no remaining CalciMedica position as of Q3 2022 after selling out during the quarter.
  • Levin Capital Strategies sold 1,071 CalciMedica shares in Q3 2022, an estimated $16K.
  • Levin Capital Strategies first reported a position in CalciMedica in Q2 2022 and held it in 1 quarter.
  • Levin Capital Strategies's CalciMedica position peaked at $16K in Q2 2022.
  • 25 funds tracked by Wall St. Rank held CalciMedica as of Q3 2022.

Based on Levin Capital Strategies's 13F filing for Q3 2022, filed 8 Nov 2022.